Dual CRISPR/Cas9 correction of compound heterozygous MARS2 mutations in the iPSC line ISMMSi060-A from a patient with COXPD25

Authors:

Abstract
No abstract available
Funding Information
  • National Institute of Neurological Disorders and Stroke (R21NS130319)
  • Icahn School of Medicine at Mount Sinai
  • National Institute of Child Health and Human Development (K08HD086827)